Related Experiment Videos

A correlation between liver plasma membrane-associated stimulatory activity (PMASA) and experimental cirrhosis

N D Belyaev1, V G Budker, L V Derij

  • 1Institute of Bioorganic Chemistry, Siberian Division of the USSR Academy of Sciences, Novosibirsk.

FEBS Letters
|January 14, 1991
PubMed

Insights

Researchers identified a novel growth factor in liver cirrhosis that stimulates cell proliferation. This membrane-associated protein, originating from hepatocytes, shows potential for understanding liver regeneration and disease progression.

Area of Science:

  • Hepatology
  • Cell Biology
  • Biochemistry

Background:

  • Carbon tetrachloride (CCl4) is a common toxin used to induce experimental liver injury and cirrhosis.
  • Liver cirrhosis is characterized by fibrosis and altered cellular function, impacting liver regeneration.
  • Understanding the molecular mechanisms driving cellular changes in cirrhosis is crucial for therapeutic development.

Purpose of the Study:

  • To identify and characterize a membrane-associated factor that stimulates cell proliferation during experimental liver cirrhosis.
  • To investigate the origin and dynamics of this growth-stimulatory factor in response to CCl4 intoxication.

Main Methods:

  • Induction of experimental cirrhosis using carbon tetrachloride (CCl4) in a rodent model.
  • In vitro proliferation assays using 3T3 cells stimulated by factors from cirrhotic liver.
  • Gel filtration chromatography to estimate the molecular mass of the active factor.
  • In situ liver perfusion to localize the source of the growth stimulatory activity.

Main Results:

  • A membrane-associated factor stimulating 3T3 cell proliferation was detected in CCl4-induced cirrhotic livers.
  • The factor exhibited an approximate molecular mass of 150 kDa.
  • Liver perfusion studies localized the activity to the peripheral plasma membrane.
  • Growth stimulatory activity increased with repeated CCl4 treatments, peaking by the tenth intoxication.
  • Activity decreased to baseline levels upon cessation of CCl4 treatment, despite persistent fibroblast accumulation, suggesting a hepatocyte origin.

Conclusions:

  • A novel, membrane-associated growth factor, likely of hepatocyte origin, is upregulated during experimental liver cirrhosis.
  • This factor plays a role in modulating cellular proliferation during liver injury.
  • The distinct kinetics of factor activity versus connective tissue proliferation suggest specific roles in the cirrhotic microenvironment.

Related Concept Videos